Table 3. Analysis of clinical variables in different clinical outcomes of oral lichen planus (OLP).
| Factors | Persistent non-erosion | Recurrent erosion | t/c 2 | p |
|---|---|---|---|---|
| Gender | 0.034 | 0.853 | ||
| Female | 17 | 6 | ||
| Male | 13 | 4 | ||
| Age (years) | 39.07 ± 12.71 | 45.00 ± 9.09 | −1.214 | 0.161 |
| Smoking | 1.195 | 0.274 | ||
| Yes | 8 | 1 | ||
| No | 22 | 9 | ||
| Drinking | 0 | 1 | ||
| Yes | 9 | 3 | ||
| No | 21 | 7 | ||
| VAS scoring | 1.57 ± 0.97 | 2.30 ± 1.57 | −1.76 | 0.213 |
| Course of disease (months) | 17.63 ± 32.90 | 17.60 ± 36.20 | 0.003 | 0.965 |
| Diagnosis | 8.547 | 0.003* | ||
| NEOLP | 24 | 3 | ||
| EOLP | 6 | 7 | ||
| Medication | 5 | 0.082 | ||
| Glucocorticoids | 15 | 1 | ||
| Glucocorticoids + immunosuppressant | 10 | 6 | ||
| Other drugs | 5 | 3 |
*p < 0.05; **p < 0.01; ***p < 0.001.